We accelerate the development of high-value biologics, one cell at a time
By combining live cell analysis with scalable single-cell genomics, our versatile platform emphasizes functional relevance to accelerate the translation of genomic discoveries into clinical applications. Our team of experts collaborates closely with customers, tailoring solutions to meet specific goals and ensuring streamlined workflow integration to deliver meaningful results.
Innovating to unlock
cellular function
Today, microscopy and sequencing are often approached as separate disciplines, limiting our ability to fully understand cellular complexity. Our integrated platform overcomes this challenge by combining high-resolution fluorescence microscopy with single-cell sequencing, providing both visual and genomic insights in a single workflow. This seamless integration enables researchers to capture cellular heterogeneity with unprecedented depth and precision.
Imaging meets genomics: A comprehensive solution
Typically, scientists must choose between observing their cells under a microscope or analyzing their molecular profile through sequencing. Flexomics bridges this gap, capturing the complexity of cellular heterogeneity by linking visual cellular features with genomic data to provide a comprehensive view of biological systems. Our platform combines the power of fluorescence microscopy with single-cell genomics, enabling the exploration of both phenotypic and molecular characteristics within an integrated, end-to-end workflow.
Image. Sequence. Integrate.
BYOA – Bring Your Own Assay.
Our FLEX picowell chip allows you to capture and query live cells by miniaturizing your favorite cellular assays for a flexible throughput of 10,000s to 100,000s of individual cells. No custom equipment required!
Our optical cell barcoding strategy is compatible with all major genomic approaches, connecting sequencing readouts and imaging-based phenotypic data
Our Latest News & Updates
Empowering the future of medicine
At Flexomics, we are driven by the vision of advancing tomorrow’s medicine. Our goal is to empower therapeutic companies with cutting-edge technology that unlocks critical insights, paving the way for the development of innovative therapies.
Our comprehensive screening platform, which bridges functional and genomic analysis in a cost-effective manner, has the potential to accelerate the development of next-generation therapeutic candidates across a wide range of indications.
Science-first collaboration, built around your vision
At Flexomics, our multidisciplinary team—spanning microscopy, sequencing, microfluidics, and computational analysis—works hand-in-hand with you to accelerate single-cell discovery.Our team works closely with you to ensure the smooth adoption of our innovative solution, customizing it to align with your unique goals and workflows.
MEET OUR TEAMCONTACT US
